|
Blood-cytokine levels as adverse outcome predictors following biomaterial implant surgery
Reference #: 01566
The University of South Carolina is offering licensing opportunities for Blood-cytokine levels as adverse outcome predictors following biomaterial implant surgery
Background:
Despite the high number of patients undergoing reconstruction surgery with surgical mesh and the relatively high number of adverse outcomes, there are currently...
Published: 7/10/2026
|
Updated: 8/2/2022
|
Inventor(s): Melissa Moss, Mihyun Waugh, Nicholas Boltin, Lauren Wolf, Ronnie Horner, Matthew Hermes, Thomas Wheeler, Richard Goodwin
Keywords(s): anti-inflammatory biotech, anti-inflammatory pharma, biomaterial implant, Blood samples, cytokines, implant rejection, inflammation, pelvic organ prolapse, plasma, predictive outcome, principal component analysis, surgical mesh
Category(s): Health Sciences
|